Contract 36E79724A0033
Melinta Therapeutics, Llc · Department Of Veterans Affairs · September 19, 2024
Melinta Therapeutics, Llc was awarded a federal contract by Department Of Veterans Affairs on September 19, 2024 for an undisclosed amount of work in pharmaceutical preparation manufacturing. This is a task or delivery order issued under parent IDIQ 36F79724D0178. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on June 10, 2025. If all options are exercised, the contract could reach $7,000.
Contract details
- PIID
- 36E79724A0033
- Parent IDIQ
- 36F79724D0178
- Award type
- —
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- September 19, 2024
- Latest action
- June 10, 2025
Description
BPA CANCELLATION
Modification timeline
-
June 10, 2025Mod P00002$0
-
December 3, 2024Mod P000012025 PL PRICING UPDATES$0
-
September 19, 2024Base awardBPA FOR REZZAYO$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36E79724A0033?
Contract 36E79724A0033 is a federal contract awarded to Melinta Therapeutics, Llc by Department Of Veterans Affairs on September 19, 2024 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 2 times since the base award.
Who won contract 36E79724A0033?
Melinta Therapeutics, Llc won contract 36E79724A0033 from Department Of Veterans Affairs.
How much is contract 36E79724A0033 worth?
Contract 36E79724A0033 has obligated $0 to date but carries a potential ceiling of $7,000 if fully funded and all options are exercised.